Editorial Comment: Electrocardiography in Pediatric Myocarditis: An Established Tool with Renewed Clinical Significance
Pakistan Heart Journal · 31.10.2026 · 59 (5) · 1670-1673
DOI: 10.47144/phj.v59i5.4019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Heart Journal, online erschienen am 31.10.2026. Verfasst von Muhammad Mohsin und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Pediatric myocarditis remains a formidable diagnostic challenge because of its heterogeneous clinical presentation, variable disease severity, and potential for rapid cardiovascular deterioration. Affected children may initially present with nonspecific manifestations, including fever, fatigue, gastrointestinal symptoms, respiratory complaints, dyspnea, or chest discomfort. However, some patients progress rapidly to ventricular dysfunction, cardiogenic shock, or life-threatening arrhythmias. Early recognition is therefore essential, particularly in resource-constrained healthcare settings where cardiac magnetic resonance imaging (CMR), endomyocardial biopsy, and specialized electrophysiological investigations may not be readily available [1-3]. Against this clinical background, the prospective study by Akbar and colleagues offers valuable insights into the electrocardiographic characteristics and arrhythmic complications of clinically suspected pediatric myocarditis in Pakistan [4]. By evaluating 106 children over a two-year period, the investigators highlight the continuing importance of the conventional 12-lead electrocardiogram (ECG) as an accessible, noninvasive, and clinically informative component of cardiovascular assessment. Although advanced cardiac imaging has substantially improved the characterization of myocardial inflammation, ECG remains indispensable for identifying electrical disturbances and supporting timely clinical decision-making [5,6]. A particularly noteworthy observation was the high prevalence of electrocardiographic abnormalities. Sinus tachycardia was documented in 96.2% of patients, while ST-T abnormalities and low-voltage QRS complexes were identified in 49.1% and 38.7%, respectively. Sustained arrhythmias occurred in 27 children (25.5%), with more than 80% of these events developing within the first 72 hours of hospitalization. These findings underscore the importance of early rhythm surveillance and suggest that the initial hospitalization period represents a critical window for detecting potentially serious electrical instability [4]. The predominance of tachyarrhythmias further emphasizes the heterogeneous electrophysiological manifestations of suspected myocarditis. Supraventricular tachycardia was the most frequently observed sustained arrhythmia, followed by ventricular tachycardia, while complete atrioventricular block and clinically significant bradyarrhythmias were also reported. This spectrum is broadly consistent with previous pediatric investigations demonstrating that myocardial inflammatory processes may be accompanied by both supraventricular and ventricular rhythm disturbances [7,8]. Nevertheless, an important diagnostic consideration concerns the potential overlap between primary myocarditis and tachycardia-induced cardiomyopathy. Sustained tachyarrhythmias may themselves produce ventricular dysfunction, heart failure, and elevations in cardiac biomarkers, thereby mimicking manifestations of acute myocardial inflammation. Consequently, some children classified as having clinically suspected myocarditis may instead have experienced tachycardia-mediated ventricular dysfunction. Without confirmatory imaging, histopathological evidence, or systematic assessment of ventricular recovery following rhythm control, this possibility cannot be fully excluded. Such diagnostic uncertainty is particularly relevant when arrhythmia represents both a presenting manifestation and an outcome of interest. Future investigations should therefore distinguish arrhythmias present at admission from those developing subsequently and, where feasible, assess changes in ventricular function after restoration of sinus rhythm. Perhaps the most clinically significant finding was the strong association between ST-T abnormalities and sustained arrhythmias. These abnormalities were present in 85.2% of children who experienced sustained arrhythmias, compared with 36.7% of those without such events. Following multivariable adjustment, ST-T abnormalities remained associated with sustained arrhythmia, yielding an adjusted odds ratio of 9.85. Previous pediatric studies have similarly indicated that repolarization disturbances may carry clinically relevant information regarding arrhythmic complications [8]. However, this association warrants cautious interpretation. First, ST-T abnormalities are not specific to myocarditis and may occur in other myocardial, metabolic, or systemic conditions. Second, because electrocardiographic abnormalities contributed to the eligibility criteria for clinically suspected myocarditis, their subsequent evaluation as predictors introduces the possibility of incorporation-related selection bias. This methodological issue may influence the magnitude and generalizability of the observed association. Moreover, ST-T abnormalities may reflect underlying myocardial injury or greater disease severity rather than functioning as independent causal determinants of arrhythmogenesis. The relatively small number of sustained arrhythmic events also limits the precision and stability of the multivariable estimates. With only 27 events, the potential for model overfitting requires consideration, particularly if several explanatory variables were included. Accordingly, the reported association should be interpreted as an exploratory risk marker rather than evidence of a validated predictive relationship. Larger, adequately powered, multicenter investigations with prespecified statistical models and external validation are necessary before ST-T abnormalities can be incorporated into a formal pediatric myocarditis risk-stratification algorithm. Another important contribution of the study is its emphasis on serial electrocardiographic assessment. A single ECG obtained at presentation may not adequately capture the evolving electrophysiological consequences of myocardial disease. The investigators employed ECG recordings at admission and at 12-hour intervals, alongside continuous cardiac monitoring. This approach recognizes that conduction abnormalities, repolarization disturbances, and clinically significant arrhythmias may emerge or evolve during hospitalization. The American Heart Association identifies clinical evaluation, cardiac biomarkers, ECG, and echocardiography as important components of the diagnostic assessment of suspected pediatric myocarditis [5]. Serial ECG evaluation, interpreted alongside clinical and echocardiographic findings, may therefore provide additional information for monitoring disease progression and detecting electrical complications. These observations are particularly relevant to healthcare systems with limited pediatric cardiac intensive-care resources. Children who developed sustained arrhythmias experienced longer hospital stays and more frequently required inotropic support. Although these associations do not establish that arrhythmias independently caused greater disease severity, they identify a subgroup with increased clinical complexity and resource requirements. Early recognition of electrocardiographic abnormalities, combined with hemodynamic assessment and appropriate monitoring, may help clinicians identify patients requiring closer observation or escalation of care. The study nevertheless has limitations that should inform the interpretation of its findings. Most importantly, the diagnosis was established using clinical manifestations, laboratory investigations, ECG findings, and echocardiographic assessment, without routine CMR or endomyocardial biopsy confirmation. The designation of clinically suspected myocarditis is therefore appropriate, but diagnostic misclassification remains possible. Furthermore, the relatively small number of arrhythmic events restricts statistical precision, while the absence of long-term follow-up prevents assessment of recurrent arrhythmias, persistent ventricular dysfunction, and subsequent cardiovascular outcomes. The observational design also precludes causal interpretation of the identified associations. Despite these limitations, the investigation provides clinically relevant evidence from a setting where access to advanced cardiovascular diagnostics may be constrained. Its findings reinforce the principle that sophisticated technology does not diminish the value of established diagnostic methods. Rather, the greatest clinical benefit is achieved when accessible tools are applied systematically, interpreted critically, and integrated with broader clinical information. Future research should prioritize multicenter prospective cohorts using standardized diagnostic definitions, systematic differentiation between primary myocarditis and tachycardia-induced cardiomyopathy, and integration of CMR when feasible. Longitudinal follow-up should assess ventricular recovery, recurrent arrhythmias, and persistent conduction abnormalities. Equally important is the development and external validation of practical risk-stratification approaches that incorporate electrocardiographic, echocardiographic, biochemical, and clinical parameters while accounting for the realities of resource-limited healthcare systems [5,9-11]. In conclusion, the conventional ECG retains substantial clinical relevance in the assessment of children with suspected myocarditis. Its principal value lies not in establishing a definitive etiological diagnosis, but in identifying electrical abnormalities, supporting serial assessment, and informing decisions about cardiac surveillance. The findings of Akbar and colleagues strengthen the rationale for systematic ECG monitoring while highlighting the need for diagnostic precision and careful interpretation of proposed arrhythmic risk markers. In pediatric myocarditis, an established diagnostic tool may continue to provide important clinical information, particularly when advanced investigations are unavailable or delayed. References Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48, 2648a-2648d. DOI: 10.1093/eurheartj/eht210 Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18(3):169-93. DOI: 10.1038/s41569-020-00435-x Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13(11):e007405. DOI: 10.1161/CIRCHEARTFAILURE.120.007405 Akbar A, Ilyas S, Amin QK, Shah DN, Ashraf S. Electrocardiographic Spectrum and Arrhythmia Profile in Children with Clinically Suspected Myocarditis: A Two-Year Prospective Observational Study from a Tertiary Care Center in Pakistan. Pak Heart J. 2026;59(05):1660-1669. DOI: 10.47144/phj.v59i5.3778 Law YM, Lal AK, Chen S, Čiháková D, Cooper LT Jr, Deshpande S, et al. Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association. Circulation. 2021;144(6):e123-35. DOI: 10.1161/CIR.0000000000001001 Buttà C, Zappia L, Laterra G, Roberto M. Diagnostic and prognostic role of electrocardiogram in acute myocarditis: a comprehensive review. Ann Noninvasive Electrocardiol. 2020;25(3):e12726. DOI: 10.1111/anec.12726 Miyake CY, Teele SA, Chen L, Motonaga KS, Dubin AM, Balasubramanian S, et al. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis. Am J Cardiol. 2014;113(3):535-40. DOI: 10.1016/j.amjcard.2013.10.021 Rasal G, Deshpande M, Mumtaz Z, Phadke M, Mahajan A, Nathani P, et al. Arrhythmia spectrum and outcome in children with myocarditis. Ann Pediatr Cardiol. 2021;14(3):366-71. DOI: 10.4103/apc.apc_207_20 Saji T, Matsuura H, Hasegawa K, Nishikawa T, Yamamoto E, Ohki H, et al. Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children. Circ J. 2012;76(5):1222-8. DOI: 10.1253/circj.CJ-11-1032 Basso C. Myocarditis. N Engl J Med. 2022;387(16):1488-500. DOI: 10.1056/NEJMra2114478 Zhang YD, Chen N, Wang QY, Li H, Zhang SY, Xia TH, et al. Global, regional, and national burden of myocarditis in children aged 0-14 years, 1990-2021: analysis for the global burden of disease study 2021. Front Public Health. 2024;12:1504586. DOI: 10.3389/fpubh.2024.1504586
Zitieren
APA
Mohsin, M., Mohsin, S., & Shaikh, A. S. (2026). Editorial Comment: Electrocardiography in Pediatric Myocarditis: An Established Tool with Renewed Clinical Significance. Pakistan Heart Journal, 59(5), 1670-1673. https://doi.org/10.47144/phj.v59i5.4019
Vancouver
Mohsin M, Mohsin S, Shaikh AS. Editorial Comment: Electrocardiography in Pediatric Myocarditis: An Established Tool with Renewed Clinical Significance. Pakistan Heart Journal. 2026;59(5):1670-1673. doi:10.47144/phj.v59i5.4019
BibTeX
@article{Mohsin2026,
author = {Mohsin, Muhammad and Mohsin, Shazia and Shaikh, Abdul Sattar},
title = {Editorial Comment: Electrocardiography in Pediatric Myocarditis: An Established Tool with Renewed Clinical Significance},
journal = {Pakistan Heart Journal},
year = {2026},
volume = {59},
number = {5},
pages = {1670--1673},
doi = {10.47144/phj.v59i5.4019}
}
EUVIMED